- Research Article
- 10.1016/j.toxlet.2025.07.843
P28-40 Potential MoA for rare fetal eye findings in rabbit prenatal developmental toxicity studies with TFA
- Sep 01, 2025
- Toxicology Letters
- Amy K Huser + 8 more +8
Publications from 2021 to 2026
Showing 10 of 12 papers
P28-40 Potential MoA for rare fetal eye findings in rabbit prenatal developmental toxicity studies with TFA
Genome-wide transcriptome analysis reveals differentially expressed genes and key signalling pathways associated with cryptorchidism in pigs
Cryptorchidism, a prevalent congenital defect in pigs, raises animal welfare and economic concerns in the breeding industry. This study utilized a genome-wide transcriptome analysis, examining samples from the pituitary gland, cremaster muscle and testis of one-week-old piglets. In the cremaster muscle of cryptorchid piglets,1225 genes exhibited significant differential expression (log2FoldChange = |2.0|, p-adjusted value ≤ 0.01). Downregulated genes were linked to biological processes like muscle tissue development and actin cytoskeleton organization. Pathway analysis further revealed the suppression of metabolic pathways including ‘Oxidative phosphorylation’, ‘TCA cycle’ and ‘Motor Proteins’. Notably, several genes integral to the motor protein pathway were significantly downregulated. Additionally, crucial genes in the noncanonical Wnt signalling pathway that regulates tissue morphogenesis and repair during the embryonic stage, were also suppressed. Our results indicate that a disruption in the normal testicular descent is accompanied by the suppression of major genes in the motor protein pathway, potentially hampering the presumed role of the cremaster muscle in testicular descent. However, we propose this to be a consequence of the down regulation of key genes in the noncanonical Wnt signalling pathway. Based on our findings, future research might be able to uncover causal mutations related to the expression of these genes.
Read moreCombined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC – The ETOP/EORTC SPLENDOUR and AMGEN-249 trials
Dynamic Formation of Asexual Diploid and Polyploid Lineages: Multilocus Analysis of Cobitis Reveals the Mechanisms Maintaining the Diversity of Clones
Given the hybrid genomic constitutions and increased ploidy of many asexual animals, the identification of processes governing the origin and maintenance of clonal diversity provides useful information about the evolutionary consequences of interspecific hybridization, asexuality and polyploidy. In order to understand the processes driving observed diversity of biotypes and clones in the Cobitis taenia hybrid complex, we performed fine-scale genetic analysis of Central European hybrid zone between two sexual species using microsatellite genotyping and mtDNA sequencing. We found that the hybrid zone is populated by an assemblage of clonally (gynogenetically) reproducing di-, tri- and tetraploid hybrid lineages and that successful clones, which are able of spatial expansion, recruit from two ploidy levels, i.e. diploid and triploid. We further compared the distribution of observed estimates of clonal ages to theoretical distributions simulated under various assumptions and showed that new clones are most likely continuously recruited from ancestral populations. This suggests that the clonal diversity is maintained by dynamic equilibrium between origination and extinction of clonal lineages. On the other hand, an interclonal selection is implied by nonrandom spatial distribution of individual clones with respect to the coexisting sexual species. Importantly, there was no evidence for sexually reproducing hybrids or clonally reproducing non-hybrid forms. Together with previous successful laboratory synthesis of clonal Cobitis hybrids, our data thus provide the most compelling evidence that 1) the origin of asexuality is causally linked to interspecific hybridization; 2) successful establishment of clones is not restricted to one specific ploidy level and 3) the initiation of clonality and polyploidy may be dynamic and continuous in asexual complexes.
Read moreFOLLISTATIN IS EXPRESSED ALONG WITH AROMATASE IN FEMALE GONADS DURING SEX DIFFERENTIATION IN THE RAINBOW TROUT
Introduction: Follistatin (Fst) is an inhibitor of some members of the TGFβ family that was first identified in mammalian ovary. This gene has been shown to be expressed in granulosa cells and oocyte of mammalian and fish species, and is involved in folliculogenesis and oocyte development. In addition to these functions in ovarian development, fst is also expressed in the mouse embryonic ovary, and its inactivation induces partial female-to-male sex reversal, suggesting that fst plays a significant role in early ovarian differentiation in mammals. However, only little is known about its potential role in early gonadal differentiation in teleost fish. Methods: Rainbow trout (Oncorhynchus mykiss) is a teleost fish with a strict male heterogametic sex determination system (XX/XY). Genetic all-male (XY) and all-female (XX) experimental populations can be produced in that species, allowing the sex-specific characterization of the early molecular events that occur before histological differentiation of the gonads. We then used the rainbow trout model to investigate the expression pattern of fst in embryonic gonads by In Situ Hybridization and qPCR, and to determine its regulation during sex differentiation in fish. Results and discussion: Shortly after hatching that occurs around 30 days post-fertilization (30 dpf), fst is already expressed in female gonads in some clusters of somatic cells, whereas no expression is detected in male gonads. Later, its expression becomes restricted to some somatic cells lining the future ovarian lamellae. This expression pattern is very similar to what is observed for the aromatase gene (cyp19a1a) coding for a key steroidogenic enzyme needed for ovarian differentiation in fish. Given that cyp19a1a is the earliest known gene to be expressed in a sexually dimorphic fashion in female gonads of rainbow trout, we compared fst and cyp19a1a expressions several days before hatching. Both fst and cyp19a1a expression begins around 26 dpf in somatic cells, in a punctiform pattern throughout the
Read moreBiology and Conservation of the European Sturgeon Acipenser sturio L. 1758
Determination of the Antioxidants’ Ability to Scavenge Free Radicals Using Biosensors
Free radicals are highly reactive molecules generated during cellular metabolism. However, their overproduction results in oxidative stress, a deleterious process that can damage cell structures, including lipids and membranes, proteins and DNA. Antioxidants respond to this problem, scavenging free radicals. This chapter critically reviews the electrochemical biosensors developed for the evaluation of the antioxidant capacity of specific compounds. Due to the ability of these devices to perform simple, fast and reliable analysis, they are promising biotools for the assessment ofantioxidant properties.
Read morePurification and characterization of human interleukin-1 beta expressed in recombinant Escherichia coli.
The high-level expression of human interleukin-1 beta in Escherichia coli is described. The protein contributes about 12% of the total cell protein and is associated with the soluble cytoplasmic fraction of the cell. A method for the purification of the protein is given which is based on anion- and cation-exchange chromatographies. The isolated protein, shown to be homogeneous by several analytical methods, has been characterized by amino acid analysis, N- and C-terminal sequence analysis and analytical centrifugation. The protein is biologically active as demonstrated by two different in vitro assays, namely, the mononuclear cell factor (IL-1/MCF) assay and lymphocyte activating factor (IL-1/LAF) assay. The specific activities determined with the IL-1/MCF and IL-1/LAF assays, are 2 X 10(7) and 4 X 10(7) units mg-1, respectively.
Read moreMolecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor.
U-937 cells, a monocytic line derived from a human histiocytic lymphoma, were induced for human tumor necrosis factor (TNF) secretion into the medium and were used for the preparation of TNF mRNA. Biological activity of the latter was quantified in a Xenopus laevis oocyte injection system. TNF mRNA was enriched by gradient centrifugation and this size-fractionated mRNA was used for synthesis of cDNA and inserted into the unique PstI site of pAT153. A recombinant plasmid containing human TNF cDNA was selected by colony hybridization using an internal fragment of a mouse TNF cDNA clone [Fransen, L., Mueller, R., Marmenout, A., Tavernier, J., Van der Heyden, J., Kawashima, E., Chollet, A., Tizard, R., Van Heuverswyn, H., Van Vliet, A., Ruysschaert, M. R. & Fiers, W. (1985) Nucleic Acids Res. 13, 4417-4429] as a probe. The sequence of this human TNF cDNA is in agreement with the one published by Pennica et al. [Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B. & Goeddel, D. V. (1984) Nature (Lond.) 312, 724-729]. The 157-amino-acid-long mature sequence is about 80% homologous to mouse TNF and its hydrophilicity plot is also very similar, in spite of the apparent species specificity of TNF. In contrast to mouse TNF, it contains no potential N-glycosylation site. When compared to other cytokines, like IFN-beta, IFN-gamma, or IL-2, there is a remarkably high preference for G X C pairs in the third-letter positions. Expression of the TNF cDNA in monkey COS cells or in Escherichia coli gives rise to a protein having similar biological and serological properties as natural human TNF. A human genomic clone was also identified and sequenced; it was found to be in good agreement with the one recently published by Shirai et al. [Shirai, T., Yamaguchi, H., Ito, H., Todd, C. W. & Wallace, R. B. (1985) Nature (Lond.) 313, 803-806], except for some differences in the introns and 5'-untranslated region.
Read moreHigh-level expression of human interferon gamma in Escherichia coli under control of the pL promoter of bacteriophage lambda